Endothelin-1 receptor drives invadopodia: Exploiting how β-arrestin-1 guides the way

References

• Murphy DA, Courtneidge SA. The ‘ins’ and ‘outs’ of podosomes and invadopodia: characteristics, formation and function. Nat Rev Mol Cell Biol 2011; 12:413-26; PMID:21697900; https://doi.org/10.1038/nrm3141
   PubMed Web of Science ®Google Scholar
• Eckert MA, Lwin TM, Chang AT, Kim J, Danis E, Ohno-Machado L, Yang J. Twist1-induced invadopodia formation promotes tumor metastasis. Cancer Cell 2011; 19:372-386; PMID:21397860; https://doi.org/10.1016/j.ccr.2011.01.036
   PubMed Web of Science ®Google Scholar
• Lohmer LL, Kelley LC, Hagedorn EJ, Sherwood DR. Invadopodia and basement membrane invasion in vivo. Cell Adhes Migration 2014; 8:246-255; https://doi.org/10.4161/cam.28406
   PubMed Web of Science ®Google Scholar
• Condeelis J, Segall JE. Intravital imaging of cell movement in tumours. Nat Rev Cancer 2003; 3:921-30; PMID:14737122; https://doi.org/10.1038/nrc1231
   PubMed Web of Science ®Google Scholar
• Gligorijevic B, Wyckoff J, Yamaguchi H, Wang Y, Roussos ET, Condeelis J. N-WASP-mediated invadopodium formation is involved in intravasation and lung metastasis of mammary tumors. J Cell Sci 2012; 125:724-734; PMID:22389406; https://doi.org/10.1242/jcs.092726
   PubMed Web of Science ®Google Scholar
• Destaing O, Petropoulos C, Albiges-Rizo C. Coupling between acto-adhesive machinery and ECM degradation in invadosomes. Cell Adh Migr 2014; 8:256-62; PMID:24727371; https://doi.org/10.4161/cam.28558
   PubMed Web of Science ®Google Scholar
• Saltel F, Daubon T, Juin A, Ganuza I E, Veillat V, Génot E. Invadosomes: intriguing structures with promise. Eur J Cell Biol 2011; 90:100-107; PMID:20605056; https://doi.org/10.1016/j.ejcb.2010.05.011
   PubMed Web of Science ®Google Scholar
• Saykali BA, El-Sibai M. Invadopodia, regulation, and assembly in cancer cell invasion. Cell Commun Adhes 2014; 21:207-12; PMID:24930891; https://doi.org/10.3109/15419061.2014.923845
   PubMed Web of Science ®Google Scholar
• Artym VV, Swatkoski S, Matsumoto K, Campbell CB, Petrie RJ, Dimitriadis EK, Li X, Mueller SC, Bugge TH, Gucek M, Yamada KM. Dense fibrillar collagen is a potent inducer of invadopodia via a specific signaling network. J Cell Biol 2015; 208:331-50; PMID:25646088; https://doi.org/10.1083/jcb.201405099
   PubMed Web of Science ®Google Scholar
• Spuul P, Ciufici P, Veillat V, Leclercq A, Daubon T, Kramer IJ, Génot E. Importance of RhoGTPases in formation, characteristics, and functions of invadosomes. Small GTPases 2014; 5:e28195; PMID:24967648; https://doi.org/10.4161/sgtp.28713
   PubMedGoogle Scholar
• Albiges-Rizo C, Destaing O, Fourcade B, Planus E, Block MR. Actin machinery and mechanosensitivity in invadopodia, podosomes and focal adhesions. J Cell Sci 2009; 122:3037-49; PMID:19692590; https://doi.org/10.1242/jcs.052704
   PubMed Web of Science ®Google Scholar
• Bravo-Cordero JJ, Oser M, Chen X, Eddy R, Hodgson L, Condeelis J. A novel spatiotemporal RhoC activation pathway locally regulates cofilin activity at invadopodia. Curr Biol 2011; 21:635-44; PMID:21474314; https://doi.org/10.1016/j.cub.2011.03.039
   PubMed Web of Science ®Google Scholar
• Pignatelli J, Tumbarello DA, Schmidt RP, Turner CE. Hic-5 promotes invadopodia formation and invasion during TGF-β-induced epithelial-mesenchymal transition. J Cell Biol 2012; 197:421-37; PMID:22529104; https://doi.org/10.1083/jcb.201108143
   PubMed Web of Science ®Google Scholar
• Schlienger S, Campbell S, Claing A. ARF1 regulates the Rho/MLC pathway to control EGF-dependent breast cancer cell invasion. Mol Biol Cell 2014; 25:17-29; PMID:24196838; https://doi.org/10.1091/mbc.E13-06-0335
   PubMed Web of Science ®Google Scholar
• Martín-Villar E, Borda-d'Agua B, Carrasco-Ramirez P, Renart J, Parsons M, Quintanilla M, Jones GE. Podoplanin mediates ECM degradation by squamous carcinoma cells through control of invadopodia stability. Oncogene 2015; 34:4531-44; https://doi.org/10.1038/onc.2014.388
   PubMed Web of Science ®Google Scholar
• Semprucci E, Tocci P, Cianfrocca R, Sestito R, Caprara V, Veglione M, Castro VD, Spadaro F, Ferrandina G, Bagnato A, Rosanò L. Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma. Oncogene 2016; 35:3432-42; PMID:26522724; https://doi.org/10.1038/onc.2015.403
   PubMed Web of Science ®Google Scholar
• Rosanò L, Spinella F, Bagnato A. Endothelin 1 in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 2013; 13:637-51; https://doi.org/10.1038/nrc3546
   PubMed Web of Science ®Google Scholar
• Rosanò L, Bagnato A. Endothelin therapeutics in cancer: Where are we? Am J Physiol Regul Integr Comp Physiol 2016; 310:469-75; https://doi.org/10.1152/ajpregu.00532.2015
   PubMed Web of Science ®Google Scholar
• Rosanò L, Cianfrocca R, Tocci P, Spinella F, Di Castro V, Spadaro F, Salvati E, Biroccio AM, Natali PG, Bagnato A. β-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced β-catenin signaling. Oncogene 2013; 32:5066-77; https://doi.org/10.1038/onc.2012.527
   PubMed Web of Science ®Google Scholar
• Rosanò L, Cianfrocca R, Masi S, Spinella F, Di Castro V, Biroccio A, Salvati E, Nicotra MR, Natali PG, Bagnato A. Beta-arrestin links endothelin A receptor to beta-catenin signalling to induce ovarian cancer cell invasion and metastasis. Proc Natl Acad Sci 2009; 106:2806-11; https://doi.org/10.1073/pnas.0807158106
   PubMed Web of Science ®Google Scholar
• Rosanò L, Spinella F, Di Castro V, Nicotra MR, Dedhar S, de Herreros AG, Natali PG, Bagnato A. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells. Cancer Res 2005; 65:11649-57; https://doi.org/10.1158/0008-5472.CAN-05-2123
   PubMed Web of Science ®Google Scholar
• Hodge RG, Ridley AJ. Regulating Rho GTPases and their regulators. Nat Rev Mol Cell Biol 2016; 17:496–510; https://doi.org/ 10.1038/nrm.2016.67
   PubMed Web of Science ®Google Scholar
• Fukuhara S, Murga C, Zohar M, Igishi T, Gutkind JS. A novel PDZ domain containing guanine nucleotide ex-change factor links heterotrimeric G proteins to Rho. J Biol Chem 1999; 274:5868-79; PMID:10026210; http://dx.doi.org/10.1074/jbc.274.9.5868
   PubMed Web of Science ®Google Scholar
• Dunn HA, Ferguson SS. PDZ Protein Regulation of G Protein-Coupled Receptor Trafficking and Signaling Pathways. Mol Pharmacol 2015; 88:624-39; PMID:25808930; https://doi.org/10.1124/mol.115.098509
   PubMed Web of Science ®Google Scholar
• Patel M, Kawano T, Suzuki N, Hamakubo T, Karginov AV, Kozasa T. Gα13/PDZ-RhoGEF/RhoA signaling is essential for gastrin-releasing peptide receptor-mediated colon cancer cell migration. Mol Pharmacol 2014; 86:252-62; PMID:24958816; https://doi.org/10.1124/mol.114.093914
   PubMed Web of Science ®Google Scholar
• Purvanov V, Holst M, Khan J, Baarlink C, Grosse R. G-protein-coupled receptor signaling and polarized actin dynamics drive cell-in-cell invasion. Elife 2014; 3; https://doi.org/10.7554/eLife.02786
   PubMed Web of Science ®Google Scholar
• Mikelis CM, Palmby TR, Simaan M, Li W, Szabo R, Lyons R, Martin D, Yagi H, Fukuhara S, Chikumi H, et al. PDZ-RhoGEF and LARG are essential for embryonic development and provide a link between thrombin and LPA receptors and Rho activation. J Biol Chem 2013; 288:12232-43; PMID:23467409; https://doi.org/10.1074/jbc.M112.428599
   PubMed Web of Science ®Google Scholar
• Shukla AK, Xiao K, Lefkowitz RJ. Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling. Trends Biochem Sci 2011; 36:57-69; https://doi.org/10.1016/j.tibs.2011.06.003
   Web of Science ®Google Scholar
• Min J, Defea K. β-arrestin-dependent actin reorganization: bringing the right players together at the leading edge. Mol Pharmacol 2011; 80:760-8; PMID:21836019; https://doi.org/10.1124/mol.111.072470
   PubMed Web of Science ®Google Scholar
• Parisis N, Metodieva G, Metodiev MV. Pseudopodial and β-arrestin-interacting proteomes from migrating breast cancer cells upon PAR2 activation. J Proteomics 2013; 80:91-106; PMID:23313222; https://doi.org/10.1016/j.jprot.2012.12.024
   PubMed Web of Science ®Google Scholar
• Law J, Zhang G, Dragan M, Postovit LM, Bhattacharya M. Nodal signals via β-arrestins and RalGTPases to regulate trophoblast invasion. Cell Signal 2014; 26:1935-42; PMID:24863882; https://doi.org/10.1016/j.cellsig.2014.05.009
   PubMed Web of Science ®Google Scholar
• Anthony DF, Sin YY, Vadrevu S, Advant N, Day JP, Byrne AM, Lynch MJ, Milligan G, Houslay MD, Baillie GS. β-Arrestin 1 inhibits the GTPase-activating protein function of ARHGAP21, promoting activation of RhoA following angiotensin II type 1A receptor stimulation. Mol Cell Biol 2011; 31:1066-75; PMID:21173159; https://doi.org/10.1128/MCB.00883-10
   PubMed Web of Science ®Google Scholar
• Yun SP, Ryu JM, Jang MW, Han HJ. Interaction of profilin-1 and F-actin via a β-arrestin-1/JNK signaling pathway involved in prostaglandin E(2)-induced human mesenchymal stem cells migration and proliferation. J Cell Physiol 2011; 226:559-71; PMID:20717968; https://doi.org/10.1002/jcp.22366
   PubMed Web of Science ®Google Scholar
• Xiao K, Sun J, Kim J, Rajagopal S, Zhai B, Villén J, Haas W, Kovacs JJ, Shukla AK, Hara MR, et al. Global phosphorylation analysis of beta-arrestin-mediated signaling downstream of a seven transmembrane receptor (7TMR). Proc Natl Acad Sci U S A 2010; 107:15299-304; PMID:20686112; https://doi.org/10.1073/pnas.1008461107
   PubMed Web of Science ®Google Scholar
• Zoudilova M, Min J, Richards HL, Carter D, Huang T, DeFea KA. beta-Arrestins scaffold cofilin with chronophin to direct localized actin filament severing and membrane protrusions downstream of protease-activated receptor-2. J Biol Chem 2010; 285:14318-29; PMID:20207744; https://doi.org/10.1074/jbc.M109.055806
   PubMed Web of Science ®Google Scholar
• Li TT, Alemayehu M, Aziziyeh AI, Pape C, Pampillo M, Postovit LM, Mills GB, Babwah AV, Bhattacharya M. Beta-arrestin/Ral signaling regulates lysophosphatidic acid-mediated migration and invasion of human breast tumor cells. Mol Cancer Res 2009; 7:1064-77; PMID:19609003; https://doi.org/10.1158/1541-7786.MCR-08-0578
   PubMed Web of Science ®Google Scholar
• Scott MG, Pierotti V, Storez H, Lindberg E, Thuret A, Muntaner O, Labbé-Jullié C, Pitcher JA, Marullo S. Cooperative regulation of extracellular signal-regulated kinase activation and cell shape change by filamin A and beta-arrestins. Mol Cell Biol 2006; 26:3432-45; PMID:16611986; https://doi.org/10.1128/MCB.26.9.3432-3445.2006
   PubMed Web of Science ®Google Scholar
• Barnes WG, Reiter E, Violin JD, Ren XR, Milligan G, Lefkowitz RJ. beta-Arrestin 1 and Galphaq/11 coordinately activate RhoA and stress fiber formation following receptor stimulation. J Biol Chem 2005; 280:8041-50; PMID:15611106; https://doi.org/10.1074/jbc.M412924200
   PubMed Web of Science ®Google Scholar
• Bhattacharya M, Anborgh PH, Babwah AV, Dale LB, Dobransky T, Benovic JL, Feldman RD, Verdi JM, Rylett RJ, Ferguson SS. Beta-arrestins regulate a Ral-GDS Ral effector pathway that mediates cytoskeletal reorganization. Nat Cell Biol 2002; 4:547-55; PMID:12105416
   PubMed Web of Science ®Google Scholar
• Kedziora KM, Leyton-Puig D, Argenzio E, Boumeester AJ, van Butselaar B, Yin T, et al. Rapid Remodeling of Invadosomes by Gi-coupled Receptors: dissecting the role of Rho GTPases. J Biol Chem 2016; 291:4323-33; PMID:26740622; https://doi.org/10.1074/jbc.M115.695940
   PubMed Web of Science ®Google Scholar
• Harper K, Arsenault D, Boulay-Jean S, Lauzier A, Lucien F, Dubois CM. Autotaxin promotes cancer invasion via the lysophosphatidic acid receptor 4: participation of the cyclic AMP/EPAC/Rac1 signaling pathway in invadopodia formation. Cancer Res 2010; 70:4634-43; PMID:20484039; https://doi.org/10.1158/0008-5472.CAN-09-3813
   PubMed Web of Science ®Google Scholar
• Ward JD, Ha JH, Jayaraman M, Dhanasekaran DN. LPA-mediated migration of ovarian cancer cells involves translocalization of Gαi2 to invadopodia and association with Src and β-pix. Cancer Lett 2015; 356:382-91; PMID:25451317; https://doi.org/10.1016/j.canlet.2014.09.030
   PubMed Web of Science ®Google Scholar
• Hwang YS, Lee J, Zhang X, Lindholm PF. Lysophosphatidic acid activates the RhoA and NF-κB through Akt/IκBα signaling and promotes prostate cancer invasion and progression by enhancing functional invadopodia formation. Tumour Biol. 2016; 37:6775-85; PMID:26662305; https://doi.org/10.1007/s13277-015-4549-x
   PubMed Web of Science ®Google Scholar
• Rosanò L, Bagnato A. β-arrestin1 at the cross-road of endothelin-1 signaling in cancer. J Exp Clin Cancer Res 2016; 35:121; https://doi.org/10.1186/s13046-016-0401-4
   PubMed Web of Science ®Google Scholar